Aqua Licensing LLC Retained to Explore the Sale of of the Compact Imaging OCT Patent Portfolio
Aqua Licensing LLC has been retained to explore the sale of of the Compact Imaging OCT patent portfolio. This patent portfolio is developed, owned and offered for sale by Compact Imaging, Inc., the developers of MRO™ (multiple reference OCT) technology. The portfolio anticipated the development of features that are now market standard in Optical Coherence Tomography (“OCT”) and Fundus imaging devices and applications. These features are deployed industry-wide in ophthalmology and have become the clinical standard of care in ophthalmic diagnostic imaging. Claim charts are available under NDA that illustrate the reads on products with covered revenue in excess of $4.7 billion. The assets are unencumbered and have not been licensed or co-developed.
For more information click HERE.